Immunethep Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 18
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 5

Immunethep General Information


Developer of anti-bacterial immunotherapies designed to prevent multi-bacterial infections. The company offers therapies include the development of neonatal vaccines to protect neonates from bacterial infections inside the mother's womb, thereby enabling patients to develop their immunity and prevent their diseases through advanced healthcare methods.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Biocant Park - Núcleo 04 Lote 3
  • Cantanhede, 3060-197
  • Portugal
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunethep Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 00000 Completed Generating Revenue
4. Later Stage VC 18-Oct-2018 00000 00000 Completed Generating Revenue
3. Grant 23-Oct-2017 000.00 Completed Generating Revenue
2. Grant 31-Mar-2017 $300K Completed Startup
1. Seed Round 30-Mar-2015 Completed Startup
To view Immunethep’s complete valuation and funding history, request access »

Immunethep Executive Team (7)

Name Title Board Seat Contact Info
Pedro Madureira Ph.D Co-Founder, Board Member & Chief Scientific Officer
Agostinho João Almeida Ph.D Co-Founder
Bruno Santos Co-Founder, Board Member & Chief Executive Officer
Eric Leire MD Chairman & President of the Board of Directors
Hugo Ramos Co-Founder
You’re viewing 5 of 7 executive team members. Get the full list »

Immunethep Board Members (4)

Name Representing Role Since
Bruno Santos Self Co-Founder, Board Member & Chief Executive Officer 000 0000
Eric Leire MD Self Chairman & President of the Board of Directors 000 0000
Pedro Madureira Ph.D Immunethep Co-Founder, Board Member & Chief Scientific Officer 000 0000
Raúl Saraiva Ph.D Self Board Member 000 0000
To view Immunethep’s complete board members history, request access »

Immunethep Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunethep Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
European Commission Government 000 0000 000000 0
Portugal Ventures Venture Capital Minority 000 0000 000000 0
Venture Catalysts Accelerator/Incubator Minority 000 0000 000000 0
Biocant Park Accelerator/Incubator Minority 000 0000 000000 0
To view Immunethep’s complete investors history, request access »